Neurological diseases are a major cause of morbidity and mortality in pregnancy. The management of multiple sclerosis, epilepsy, myasthenia gravis, certain neuropathies and headache in pregnancy is described; the potentially life-threatening conditions of stroke and eclampsia are also discussed. Management of most neurological conditions is similar to outside of pregnancy, but special consideration should be given to delivery plans and the safety of medications antenatally and during breastfeeding. Pre-pregnancy counselling, regular review and effective communication among a multi-disciplinary team are key to optimising management and outcomes.
BrennerB.Haemostatic changes in pregnancy. Thromb Res 2004; 114:409–14. http://dx.doi.org/10.1016/j.thromres.2004.08.004
4.
SarasteMVaisanenSAlanenA Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancy. Gend Med 2007; 4:45–55. http://dx.doi.org/10.1016/S1550-8579(07)80008-8
5.
AndersonGD.Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005; 44:989– 1008. http://dx.doi.org/10.2165/00003088-200544100-00001
6.
AscherioAMungerKL.Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007; 61:288–99. http://dx.doi.org/10.1002/ana.21117
7.
PugliattiMRosatiGCartonH The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006; 13:700–22. http://dx.doi.org/10.1111/j.1468-1331.2006.01342.x
8.
VukusicSHutchinsonMHoursM Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 2004; 127:1353–60. http://dx.doi.org/10.1093/brain/awh152
9.
SalminenHJLeggettHBoggildM. Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. J Neurol 2010; 257:2020–3. http://dx.doi.org/10.1007/s00415-010-5652-y
10.
LuEWangBWGuimondC Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review. Neurology 2012; 79:1130–5. http://dx.doi.org/10.1212/WNL.0b013e3182698c64
11.
HaasJHommesOR.A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis. Mult Scler 2007; 13:900–8. http://dx.doi.org/10.1177/1352458506075654
12.
VukusicSIonescuIEl-EtrM The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART’MUS) trial: rationale, objectives and state of advancement. J Neurol Sci 2009; 286:114–8. http://dx.doi.org/10.1016/j.jns.2009.08.056
13.
MacDonaldBKCockerellOCSanderJW The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000; 123:665–76. http://dx.doi.org/10.1093/brain/123.4.665
14.
PlaucheWC.Myasthenia gravis in mothers and their newborns. Clin Obstet Gynecol 1991; 34:82–99. http://dx.doi.org/10.1097/00003081-199103000-00012
15.
HoffJMDaltveitAKGilhusNE.Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology 2003; 61:1362– 6. http://dx.doi.org/10.1212/01.WNL.0000082725.21444.EC
BashukRGKrendelDA.Myasthenia gravis presenting as weakness after magnesium administration. Muscle Nerve 1990; 13:708–12. http://dx.doi.org/10.1002/mus.880130808
18.
CatanzariteVAMcHargueAMSandbergECRespiratory arrest during therapy for premature labor in a patient with myasthenia gravis. Obstet Gynecol1984; 64:819–22.
19.
AhmadS.Myasthenia gravis unmasked by ergonovine. Am Heart J 1991; 121:1851. http://dx.doi.org/10.1016/0002-8703(91)90070-X
20.
HoffJMDaltveitAKGilhusNE.Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol 2007; 14:38–43. http://dx.doi.org/10.1111/j.1468-1331.2006.01538.x
21.
GamblingDRDouglasMJMcKayRSF.Obstetric anesthesia and uncommon disorders. Cambridge: Cambridge University Press; 2008. http://dx.doi.org/10.1017/CBO9780511544552
22.
DillonFX.Anesthesia issues in the perioperative management of myasthenia gravis. Semin Neurol 2004; 24:83–94. http://dx.doi.org/10.1055/s-2004-829587
23.
RasmussenBKJensenRSchrollM Epidemiology of headache in a general population: a prevalence study. J Clin Epidemiol 1991; 44:1147–57. http://dx.doi.org/10.1016/0895-4356(91)90147-2
24.
ScherAITerwindtGMPicavetHS Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005; 64:614–20. http://dx.doi.org/10.1212/01.WNL.0000151857.43225.49
25.
FacchinettiFAllaisGNappiRE Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia 2009; 29:286–92. http://dx.doi.org/10.1111/j.1468-2982.2008.01704.x
26.
SomervilleB.Estrogen-withdrawal migraine II. Attempted prophylaxis by continuous estradiol administration. Neurology 1975; 25:245–50. http://dx.doi.org/10.1212/WNL.25.3.245
27.
SomervilleBW.The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972; 22:355–65. http://dx.doi.org/10.1212/WNL.22.4.355
28.
ErtresvagJMZwartJAHeldeG Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurol Scand 2005; 111:233–7. http://dx.doi.org/10.1111/j.1600-0404.2005.00350.x
29.
CripeSMFrederickIOQiuC Risk of preterm delivery and hypertensive disorders of pregnancy in relation to maternal co-morbid mood and migraine disorders during pregnancy. Paediatr Perinat Epidemiol 2011; 25:116–23. http://dx.doi.org/10.1111/j.1365-3016.2010.01182.x
30.
JamesAHBushnellCDJamisonMG Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005; 106:509–16. http://dx.doi.org/10.1097/01.AOG.0000172428.78411.b0
31.
SztajzelRGenoudDRothS Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002; 13:102–6. http://dx.doi.org/10.1159/000047758
32.
RasmussenBK.Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993; 53:65–72. http://dx.doi.org/10.1016/0304-3959(93)90057-V
33.
NestoriucYRiefWMartinA. Meta-analysis of biofeedback for tension-type headache: efficacy, specificity, and treatment moderators. J Consult Clin Psychol 2008; 76:379–96. http://dx.doi.org/10.1037/0022-006X.76.3.379
OlesenCSteffensenFHSorensenHT Pregnancy outcome following prescription for sumatriptan. Headache 2000; 40:20–4. http://dx.doi.org/10.1046/j.1526-4610.2000.00003.x
37.
HollandSSilbersteinSDFreitagF Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012; 78:1346–53. http://dx.doi.org/10.1212/WNL.0b013e3182535d0c
38.
EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006; 66:354–60. http://dx.doi.org/10.1212/01.wnl.0000195888.51845.80
39.
CantwellRClutton-BrockTCooperG Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG 2011; 118:1–203. http://dx.doi.org/10.1111/j.1471-0528.2010.02847.x
40.
BardyA.Seizure frequency in epileptic women during pregnancy and the pueperium: results of the prospective Helskinki study. In: Hanz D, Bossi L, Dam M et al, editors. Epilepsy, pregnancy, and the child. New York: Raven Press; 1982. p.27–37.
41.
BassiV.Epilepsy. In: Hainline B, Devinsky O. Neurological complications of pregnancy. Philadelphia: Lippincott, Williams &Wilkins; 2002.
KaplanP.Neurological aspects of eclampsia, In: Hainline B, Devinsky O. Neurological complications of pregnancy. Philadelphia: Lippincott, Williams &Wilkins; 2002.
46.
Nelson-PiercyC.Handbook of obstetric medicine. London: Informa HealthCare; 2006.
47.
LiangCCChangSDLaiSL Stroke complicating pregnancy and the puerperium. Eur J Neurol 2006; 13:1256–60. http://dx.doi.org/10.1111/j.1468-1331.2006.01490.x
48.
WiebersDOThe incidence of stroke among pregnant women in RochesterWhisnant JP., Minn, 1955 through 1979. JAMA 1985; 254:3055–7. http://dx.doi.org/10.1001/jama.1985.03360210071032
49.
SharsharTLamyCIncidenceMas JL.ofcauses strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke 1995; 26:930–6. http://dx.doi.org/10.1161/01.STR.26.6.930
50.
ScottCABewleySRuddA Incidence, risk factors, management, and outcomes of stroke in pregnancy. Obstet Gynecol 2012; 120:318–24. http://dx.doi.org/10.1097/AOG.0b013e31825f287c
51.
KuklinaEVTongXBansilP Trends in pregnancy hospitalizations that included a stroke in the United States from 1994 to 2007: reasons for concern? Stroke 2011; 42:2564–70. http://dx.doi.org/10.1161/STROKEAHA.110.610592
52.
RothwellPMCoullAJGilesMF Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004; 363:1925–33. http://dx.doi.org/10.1016/S0140-6736(04)16405-2
53.
OgilvyCSStiegPEAwadI Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Circulation 2001; 103:2644–57. http://dx.doi.org/10.1161/01.CIR.103.21.2644
54.
GrossBADuR. Hemorrhage from arteriovenous malformations during pregnancy. Neurosurgery 2012; 71:349–55; discussion 55–6. http://dx.doi.org/10.1227/NEU.0b013e318256c34b
55.
BatesSMGreerIAPabingerIVenous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest2008; 133:844S–86S.
56.
LanskaDJKryscioRJ.Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000; 31:1274– 82. http://dx.doi.org/10.1161/01.STR.31.6.1274
57.
Nelson-PiercyC.Handbook of obstetric medicine. 3rd ed. London: Informa Healthcare; 2010. p. 193.
58.
PaduaLADi PasqualePazzagliaCSystematic review of pregnancy related carpal tunnel syndrome. Muscle Nerve2010; 42:697–702.
59.
DonaldsonJ.Neurology of pregnancy. Philadelphia: WB Saunders; 1989.
60.
KatzASergienkoRDiorU Bell's palsy during pregnancy: is it associated with adverse perinatal outcome? Laryngoscope 2011; 121:1935–8;
61.
Hilsinger RL Jr, Adour KK, Doty HE. Idiopathic facial paralysis, pregnancy, and the menstrual cycle. Ann Otol Rhinol Laryngol1975; 84:433–42.
